½Å¼¼Æ÷¾Ï ȯÀÚ¿¡¼ Ç÷Áß Immunosuppressive Acidic Protein(IAP)ÀÇ ÀÇÀÇ
Serum Immunosuppressive Acidic Protein(IAP) as a Tumor Marker for Renal Cell Carcinoma
±è»óÁø, ÃÖÁ¤ÈÆ, ä¼öÀÀ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è»óÁø ( )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÃÖÁ¤ÈÆ ( )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ä¼öÀÀ ( )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358319990400030292
Abstract
¼·Ð
ÃÖ±Ù °Ç°°ËÁø¿¡ ´ëÇÑ ÀϹÝÀεéÀÇ °ü½É ¹× ÀÌÇØÀÇ Áõ°¡¿¡ µû¶ó ½Å¼¼Æ÷¾ÏÀÌ Á¶±â¿¡ ¹ß°ßµÇ
¾î ¼ö¼ú¿ä¹ýÀ¸·Î Ä¡·áµÇ´Â °æ¿ì°¡ ¸¹¾ÆÁ³À¸¸ç ±× Ä¡·á È¿°úµµ Àüº¸´Ù ¸¹ÀÌ Çâ»óµÇ¾ú´Ù. ±×
·¯³ª ÀÓ»óÀûÀ¸·Î Á¾¾çÀÌ ½ÅÀå ³»¿¡¸¸ ±¹ÇѵǾî ÀÖ´Â °æ¿ì¿¡µµ ¼ö¼ú·Î Á¾¾çÀ» Á¦°ÅÇÑ ÈÄ ¾à
¹Ý ¼ö À̻󿡼´Â ´Ù½Ã Àç¹ßÇÒ ¼ö Àִµ¥, ÀÏ´Ü Àç¹ßµÈ ½Å¼¼Æ÷¾ÏÀ¸·Î ÀÌÇàµÈ °æ¿ì¿¡´Â Ç×¾Ï
Á¦ ¿ä¹ý, È£¸£¸ó ¿ä¹ý ¶Ç´Â ¹æ»ç¼± ¿ä¹ý µî¿¡ Àß µèÁö ¾ÊÀ¸¸ç ¿¹ÈÄ°¡ ÁÁÁö ¾ÊÀº ÆíÀÌ´Ù. µû
¶ó¼ ±ÙÄ¡Àû¼ö¼ú ¿ä¹ý µîÀ¸·Î ¿ø¹ß¼º Á¾¾çÀ» Á¦°ÅÇÑ ÈÄ ÃßÀû°üÂûÇÏ´Â °úÁ¤¿¡¼ Á¾¾çÀÇ Àç¹ß
À̳ª ´Ù¸¥ ºÎÀ§·ÎÀÇ ÀüÀ̸¦ »çÀü¿¡ ¿¹ÃøÇÒ ¼ö ÀÖ°í ÀüÀÌ°¡ µÈ °æ¿ì¶óµµ Ãʱ⠴ܰèÀÎ Çö¹Ì°æ
Àû ÀüÀÌ´Ü°è¿¡ Áø´ÜÇØ ³¾ ¼ö ÀÖ´Â Á¾¾çÇ¥ÁöÀÚÀÇ °³¹ßÀÌ ¹«¾ùº¸´Ù Áß¿äÇÏ´Ù ÇÏ°Ú´Ù. ÀÌÁ¦±î
Áö alpha-fetoprotein, c-terminal parathyroid hormone, LDH, CEAµîÀÇ ¿©·¯ Ç÷û Á¾¾çÁöÇ¥
µéÀÌ º¸°íµÇ¾úÀ¸³ª È¿¿ë¼ºÀº ±×¸® ³ôÁö ¾ÊÀº ÆíÀÌ´Ù.
immunosuppressive acidic protein(IAP)Àº ºÐÀÚ·®ÀÌ 50,000DaÀÌ°í ¾ËÆÄ 1 ÇüÅÂÀÇ »ê¼º´ç
´Ü¹éÁú·Î¼ °£¼¼Æ÷, ´ë½Ä¼¼Æ÷, °ú¸³±¸ µî¿¡¼ ±â¿øÇÏ¸ç ½ÃÇè°ü ³»¿¡¼ È¥ÇÕ ¸²ÇÁ±¸¹ÝÀÀ°ú ÇÇ
ÅäÇð¾Æ±Û·çƼ´Ñ ¸²ÇÁ¸ð±¸ Çü¼ºÀ» ¾ïÁ¦½ÃÅ°´Â °ÍÀ¸·Î ¾Ë·ÁÁ® Àִµ¥, ¾ÆÁ÷ ±× Á¤È®ÇÑ ±âÀü¿¡
´ëÇؼ´Â ¾Ë·ÁÁöÁö ¾Ê¾ÒÁö¸¸ ÀÌ·¯ÇÑ IAP°¡ ¿©·¯ ¾Ç¼ºÁúȯ°ú Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, º£Ã¼Æ®º´ µî
ÀÇ ÀÚ°¡¸é¿ªÁúȯ, ±æ¶û-¹Ù·¹ ÁõÈıº µîÀÇ ¿°Áõ¼º ½Å°æÁúȯµé¿¡¼ Áõ°¡µÈ´Ù°í º¸°íµÇ¾úÀ¸¸ç,
¶ÇÇÑ Ç÷¾×Åõ¼®À» ¹Þ´Â ¸»±â ½ÅÀåÁúȯ ȯÀÚ¿¡¼µµ Áõ°¡µÈ °æ¿ì°¡ º¸°íµÇ¾ú´Ù.
ÀÌ¿Í °°ÀÌ IAP°¡ ¾î¶² ƯÁ¤Áúȯ¿¡ ´ëÇؼ¸¸ ƯÀÌÀûÀÎ »ó½ÂÀ» º¸ÀÌ´Â °ÍÀº ¾Æ´ÏÁö¸¸ »ó½Â
À» º¸ÀÌ´Â Áúȯµé¿¡¼´Â, ÀÚ°¡¸é¿ªÁúȯÀÇ È°µ¿Ç¥ÁöÀڷμÀÇ Àǹ̰¡ ÀÖÀ» ¼ö ÀÖ°í, ³¼Ò¾ÏÀÌ
³ª ½Å¼¼Æ÷¾Ï°ú °°Àº ¾Ç¼ºÁ¾¾çÀÇ °æ¿ì¿¡´Â ÀÓ»óÀûÀ¸·Î Á¾¾çÇ¥ÁöÀڷμ °¡Ä¡°¡ ÀÖ´Ù°í º¸°íµÇ
°í ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚµéÀº ½Å¼¼Æ÷¾ÏÀÇ Á¾¾çÇ¥ÁöÀڷμ IAPÀÇ ÀÇÀǸ¦ ¾Ë¾Æº¸°í ±× ÀÓ»óÀû À¯¿ë
¼º¿¡ ´ëÇÏ¿© Æò°¡ÇÏ°íÀÚ ½Å¼¼Æ÷¾Ï ȯÀÚ¸¦ ´ë»óÀ¸·Î Ä¡·á Àü Ç÷Áß IAP¸¦ ÃøÁ¤ÇÏ°í, Á¾¾çÀÇ
ÀÓ»óÀû ¹× º´¸®ÇÐÀû ¼Ò°ß µî°úÀÇ »ó°ü°ü°è¸¦ ºÐ¼®ÇÏ¿´´Ù.
Purpose : We assessed the significance of immunosuppressive acidic protein(IAP) as a
tumor marker for renal cell carcinoma.
Materials and Methods : The serum concentration of IAP was determined in
88patients with renal cell carcinoma and in 12 healthy adults by turbidometric
immunoassay. We examined the prognostic value of the serum IAP level and its
association with other clinicopathological parameters such as tumor stage and grade.
Results : The mean value of serum IAP in patients with renal cell carcinoma (643.0¡¾
447.5§¶/§¢) was statistically higher than that of the control group (320.4¡¾79.0§¶/§¢).
Positive rates of IAP were noticed as 22.2%, 56.9%, 57.9%, and 100% of patients in
stages T1, T2, T3, and T4, respectively. The mean value of serum IAP in metastatic
patients(1159.6¡¾711.7§¶/§¢) was higher than that in non-metastatic patients (553.5¡¾313.4
§¶/§¢)(p=0.0001). In high grade tumors (Fuhrman's muclear grade ¥²/¥³), IAP level
(693.5¡¾385.14§¶/§¢) was higher than that (507.1¡¾305.44§¶/§¢) of low grade tumors(grade
¥°/¥±)(p=0.006).
Conclusions : Serum IAP seems to be useful as diagnostic and followup tumor marker
in patients with renal cell carcinoma.
Å°¿öµå
Renal cell carcinoma; Tumor markers; Biological; Immunosuppressvie acidic protein;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸